NCIC CTG Trial IND.138 (Gilead Sciences protocol number 110-06)Randomized Phase 2 Study of NX 211 given by two diffrent intravenous schedules in advanced and/or recurrent epithelial ovarian cancer

  • Poole, Christopher (Principal Investigator)

Project Details

Short titleNCIC CTG Trial IND.138 (Gilead Sciences protocol number 110-06)Randomized Phase 2 Study of NX 211 given by two diffrent intravenous schedules in advanced and/or recurrent epithelial ovarian cancer
StatusFinished
Effective start/end date1/01/01 → 30/06/03

Funding

  • NATIONAL CANCER INSTITUTE OF CANADA CTG